Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidit Sharma

Showing results (151-160 of 187) with videos related to

Pageof 19
Sort By:
The Journal of Urology|November 9, 2022
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate CancerJack R Andrews, Mohamed E Ahmed, Vidit Sharma, et al.
BJU International|May 12, 2026
Biochemical Recurrence Irradiation or Observation (BRIO) in patients with prostate cancer: protocol for a randomised control trialNancy Wei, Ryan M Phillips, Eugene Kwon, et al.
The Journal of Urology|December 2, 2024
Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival OutcomesMohamed E Ahmed, Jack R Andrews, Ahmed M Mahmoud, et al.
Human Pathology|August 4, 2022
Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumorsSounak Gupta, Andrew L Folpe, Jorge Torres-Mora, et al.
Cancers|February 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder CancerAbby L Grier, Jeffrey Y Zhong, Spyridon Basourakos, et al.
Histopathology|December 27, 2023
Metastatic clear cell papillary renal cell 'tumour'Sounak Gupta, Surendra Dasari, Vidit Sharma, et al.
The Journal of Urology|January 9, 2018
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?Daniel P Nguyen, Emily A Vertosick, Vidit Sharma, et al.
The Prostate|June 8, 2026
Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection CriteriaEric V Li, Eman E Ahmed, Mohamed E Ahmed, et al.
Kidney360|October 1, 2025
Spatial Mass Spectrometry-Based Proteomic Analysis of Normal-Appearing Glomeruli from Young and Old AdultsKiran K Mangalaparthi, Gunveen S Sachdeva, Afsana Ansari Shaik, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2015
Comparative effectiveness of adrenal sparing radical nephrectomy and non-adrenal sparing radical nephrectomy in clear cell renal cell carcinoma: Observational study of survival outcomesGregory J Nason, Leon G Walsh, Ciaran E Redmond, et al.
Pageof 19

Showing results (151-160 of 187) with videos related to

Sort By:
Pageof 19
The Journal of Urology|November 9, 2022
Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate CancerJack R Andrews, Mohamed E Ahmed, Vidit Sharma, et al.
BJU International|May 12, 2026
Biochemical Recurrence Irradiation or Observation (BRIO) in patients with prostate cancer: protocol for a randomised control trialNancy Wei, Ryan M Phillips, Eugene Kwon, et al.
The Journal of Urology|December 2, 2024
Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival OutcomesMohamed E Ahmed, Jack R Andrews, Ahmed M Mahmoud, et al.
Human Pathology|August 4, 2022
Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumorsSounak Gupta, Andrew L Folpe, Jorge Torres-Mora, et al.
Cancers|February 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder CancerAbby L Grier, Jeffrey Y Zhong, Spyridon Basourakos, et al.
Histopathology|December 27, 2023
Metastatic clear cell papillary renal cell 'tumour'Sounak Gupta, Surendra Dasari, Vidit Sharma, et al.
The Journal of Urology|January 9, 2018
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?Daniel P Nguyen, Emily A Vertosick, Vidit Sharma, et al.
The Prostate|June 8, 2026
Outcomes of Patients With Favorable Intermediate Risk Gleason Grade Group 2 Prostate Cancer Undergoing Radical Prostatectomy in the MRI Era: Refining Active Surveillance Selection CriteriaEric V Li, Eman E Ahmed, Mohamed E Ahmed, et al.
Kidney360|October 1, 2025
Spatial Mass Spectrometry-Based Proteomic Analysis of Normal-Appearing Glomeruli from Young and Old AdultsKiran K Mangalaparthi, Gunveen S Sachdeva, Afsana Ansari Shaik, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2015
Comparative effectiveness of adrenal sparing radical nephrectomy and non-adrenal sparing radical nephrectomy in clear cell renal cell carcinoma: Observational study of survival outcomesGregory J Nason, Leon G Walsh, Ciaran E Redmond, et al.
Pageof 19